As a company, our number one goal is helping people by bringing products to market that improve quality of life. All our drug treatments and biomedical technologies fit our mission to deliver breakthrough products and services that reduce invasiveness and enhance daily living. We strive to improve the lives of people facing obesity, infertility and intimacy issues. Our products include ground breaking drug treatments and biomedical technologies, including ToConceive, C and Extrinsa.
Quote | Callitas Health Inc (OTCMKTS:MPHMF)
Last: | $0.013 |
---|---|
Change Percent: | 0.0% |
Open: | $0.013 |
Close: | $0.013 |
High: | $0.013 |
Low: | $0.013 |
Volume: | 1,000 |
Last Trade Date Time: | 10/01/2021 04:55:24 pm |
News | Callitas Health Inc (OTCMKTS:MPHMF)
CINCINNATI, OH / ACCESSWIRE / June 12, 2019 / Callitas Health Inc. ("Callitas" or the "Company") (CSE: LILY, OTCQB: MPHMF, FWB: T3F3) provides its third bi-weekly Default Status Report under National Policy 12-203 Management Cease Trade Orders ("NP 12-203"), pursuant to which Callitas issu...
CINCINNATI, OH / ACCESSWIRE / May 30, 2019 / Callitas Health Inc. ("Callitas" or the "Company") (CSE: LILY, OTCQB: MPHMF, FWB: T3F3) provides its second bi-weekly Default Status Report under National Policy 12-203 Management Cease Trade Orders ("NP 12-203"), pursuant to which Callitas iss...
Message Board Posts | Callitas Health Inc (OTCMKTS:MPHMF)
Subject | By | Source | When |
---|---|---|---|
MPHMF: inactive security. FINRA deleted symbol: | Renee | investorshub | 10/17/2022 10:05:37 PM |
$LILY: CSE /$ MPHMF | Greta Grabo | investorshub | 12/19/2018 1:57:03 PM |
$LILY / $MPHMF | Greta Grabo | investorshub | 12/17/2018 2:06:57 PM |
$LILY: CSE / $MPHMF | Greta Grabo | investorshub | 12/12/2018 2:12:42 PM |
$LILY.V / $MPHMF - The Medical | Greta Grabo | investorshub | 12/10/2018 10:06:30 AM |
News, Short Squeeze, Breakout and More Instantly...
Callitas Health Inc Company Name:
MPHMF Stock Symbol:
OTCMKTS Market:
CINCINNATI, OH / ACCESSWIRE / June 12, 2019 / Callitas Health Inc. ("Callitas" or the "Company") (CSE: LILY, OTCQB: MPHMF, FWB: T3F3) provides its third bi-weekly Default Status Report under National Policy 12-203 Management Cease Trade Orders ("NP 12-203"), pursuant to which Callitas issu...
CINCINNATI, OH / ACCESSWIRE / May 30, 2019 / Callitas Health Inc. ("Callitas" or the "Company") (CSE: LILY, OTCQB: MPHMF, FWB: T3F3) provides its second bi-weekly Default Status Report under National Policy 12-203 Management Cease Trade Orders ("NP 12-203"), pursuant to which Callitas iss...
NOT FOR ISSUANCE IN THE UNITED STATES CINCINNATI, OH / ACCESSWIRE / May 23, 2019 / Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the ''Company'' or ''Callitas''), an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, announced ...